Share Prices & Company Research

Stockbroking

Angle

Current Price 65.60p Bid 65.00p Ask 67.00p Change 0.00%
Last Updated: 15/11/2019 17:43. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

ANGLE plc is a world-leading liquid biopsy company commercialising a disruptive platform technology that can capture cells circulating in blood, such as cancer cells, even when they are as rare in number as one cell in one billion blood cells, and harvest the cells for analysis. ANGLE's cell separation technology is called the ParsortixTM system and it enables a liquid biopsy (simple blood test) to be used to provide the cells of interest. Parsortix is the subject of granted patents in Europe, the United States, Canada, India, China, Japan and Australia and three extensive families of patents are being progressed worldwide. The system is based on a microfluidic device that captures live cells based on a combination of their size and compressibility. The ParsortixTM system has a CE Mark for Europe and FDA authorisation is in process for the United States. ANGLE has established formal collaborations with world-class cancer centres.

Financial Highlights Year Ended 30/04/2019

Turnover
£0.68m
Operating Profit
£-10.90m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-10.06

Key Personnel

Andrew David William Newland
Chief Executive
Ian Francis Griffiths
Finance Director
Garth Robert Selvey
Non-Executive Chairman
Brian Howlett
Non-Executive Director
Dr Jan Groen
Non-Executive Director

Stock Details

EPIC
AGL
ISIN
GB0034330679
Shares in Issue
172,754,816
Market cap
£114.02m
Sector

Analyst Views (1)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
100.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
66.00p
Bid Price
65.00p
Ask Price
67.00p
Volume
49749
Change Today
0.00p
% Change Today
0.00%
Open
65.36p
Previous Close
66.00p
Intraday High
67.00p
Intraday Low
65.04p
52 Week High
84.50p
52 Week Low
38.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Angle Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Apr 2019
30 Apr 2018
Tangible Assets
1.4
1.5
Intangible Assets & Goodwill
6.8
5.6
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
8.2
7.1
Inventory
1.0
0.6
Trade & Receivables
0.9
0.8
Cash & Receivables
11.0
7.7
Other Current Assets & Assets Held for Resale
1.9
2.2
Total Assets
23.0
18.3

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
30 Apr 2019
30 Apr 2018
Short Term Liabilities
3.7
2.4
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
3.7
2.4

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Apr 2019
30 Apr 2018
Net Assets
19.3
15.9

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
30 Apr 2019
30 Apr 2018
Share Capital
14.4
11.7
Minority Interests
0.0
-0.7
Retained Earnings
-51.6
-42.1
Share Premium Account
52.8
43.5
Other Equity
3.8
3.5
Total Equity
19.3
15.9

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
30 Apr 2019
30 Apr 2018
Cashflow from Operating Activities
-7.3
-6.8
Cashflow Before Financing
-8.6
-12.3
Increase / Decrease in Cash
3.4
2.1

Income (£m)

Data has been provided by AJ Bell

Reporting Date
30 Apr 2019
30 Apr 2018
Turnover
0.7
0.6
Cost of Sales
0.2
0.2
Gross Profit
0.5
0.5
Operating Profit
-10.9
-8.9
Pre-Tax Profit
-10.9
-8.9
Profit / Loss for the Year
-8.9
-7.5
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.